Eli Lilly and Co. (LLY) emerged as a beacon of optimism last week in a market filled with uncertainty and volatility. Shares ...

Shares in pharmaceuticals firm Eli Lilly (LLY) rose today after it said it was suing companies ripping off its weight-loss ...

We recently published a list of Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks.

Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Pharmaceutical giant Eli Lilly represents a powerful player in healthcare, bolstering the bullish case. However, valuation ...

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Eli Lilly and (NYSE:LLY) with a Overweight ...

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week.

We recently published a list of the 10 Best Long Term Stocks to Buy According to Billionaires. In this article, we are going ...